It was a banner year for new stocks. In all, 268 companies came public and the average return was about 21%. This compares to a 13% gain in the S&P 500 and a 15% gain in the Nasdaq Composite.
Of all the new stocks that hit the market, there were 24 that posted gains of more than 100%. Interestingly enough, only five of these were tech operators. Biotech was particularly strong — 18 deals in that sector returned more than 100%, more than in any other sector.
No doubt, the market for new stocks was far from perfect. Consider that 18 offerings lost more than half their value. As for the worst deal, it was Amedica (AMDA). The company lost 87% for the year. Read